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Recent studies have demonstrated a high prevalence of
human papillomavirus (HPV) types originally believed
to be restricted to patients with epidermodysplasia
verruciformis (EV) in benign and malignant skin tumors
of the general population. Other groups detected typical
mucosal HPV in skin tumors. We have investigated
recurrent leukoplakial cutaneous and mucosal lesions
located around the ileostoma of a woman with ulcerative
colitis for the presence of HPV. Cutaneous, muco-
cutaneous, and mucosal ileostoma-biopsies were
analyzed by three different polymerase chain reaction
protocols for genital, cutaneous, and cutaneous EV-
associated HPV types. Polymerase chain reaction
products were cloned, sequenced, and submitted to
phylogenetic analyses. HPV-DNA sequences of the EV-
Human papillomaviruses (HPV) infect epithelial cells ofmucous membranes and of the skin and can lead to alarge variety of benign and malignant epithelial tumors(for review see zur Hausen, 1994; IARC, 1995;Wieland and Pfister, 1997). Today, 80 HPV types and
numerous novel HPV-DNA fragments have been identified (Myers
et al, 1996). HPV types are genotypes. A new type has to differ in its
L1 gene DNA sequence by at least 10% from every other known HPV
type. HPV subtypes and variants are defined as having viral DNA
sequence similarities between 90 and 98% or above 98%, respectively
(Wheeler and Icenogle, 1995; van Ranst et al, 1996). Papillomaviruses
are phylogenetically classified into groups A–E. Human papil-
lomaviruses belong to group A (mainly genital HPV), B [epidermodys-
plasia verruciformis (EV)-HPV], or E (cutaneous PV) (Chan et al,
1995; Myers et al, 1996). HPV types found in the skin as HPV1–4,
10, 26–29 are mainly associated with benign neoplasms (Myers et al,
1996; Gross et al, 1997). Recently, known and putatively novel HPV
types of the EV-HPV group B1 have been found in benign and
malignant skin tumors of immunocompromised (transplant recipients)
and immunocompetent patients (Tieben et al, 1994; Berkhout et al,
1995; de Jong-Tieben et al, 1995; Ho¨pfl et al, 1997). Others have
found cutaneous HPV (groups B2 and E) or typical mucosal genital
HPV types (group A) in benign and malignant skin tumors (Euvrard
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HPV group could be detected in all biopsies, whereas
genital/mucosal or cutaneous HPV types were not found.
HPV types detected comprised HPV20, HPV23, HPV38,
and four putatively novel HPV types that belong to
different clusters of the EV-HPV group B1. Different
HPV types prevailed in cutaneous, mucocutaneous, and
mucosal lesions and the number of HPV sequences found
per lesion varied between one and three. Our data show
the association of recurrent lesions around a stoma and
at the ileum with known and novel EV-HPV types. These
results emphasize the plurality of HPV and yield data
for the possible transmission of cutaneous HPV to
mucosal areas of the intestine. Key words: intestine/leuko-
plakia/polymerase chain reaction. J Invest Dermatol 111:164–
168, 1998
et al, 1993; Soler et al, 1993; Shamanin et al, 1994, 1996; Stark et al,
1994; for review see Pfister and Ter Schegget, 1997). In this study we
describe the association of known and putatively novel EV-HPV types
with benign recurrent cutaneous, mucocutaneous, and mucosal lesions
around an ileostoma.
MATERIALS AND METHODS
Clinical data and histology A 55 y old woman presented in 1995 with
recurrent and increasing papillomatous lesions around her ileostoma. The
patient’s primary disease was ulcerative colitis since 1975. She had had a
colectomy and establishment of an ileostoma with a Kock’s pocket in her right
lower abdominal quadrant in 1982. Since 1990 she had had several small
revisions of the stoma because of the formation of leukoplakia-like lesions at
the skin-mucosa transition. In June 1995 her clinical findings were grayish-
white, papillomatous plaques on the upper circumference of the ileostoma with
a sharp outline and with a downward extension of 7–10 mm into the ileum
(Fig 1). In the skin area surrounding the ileostoma no irritation was present.
An endoscopic examination of the ileum in July 1995 only revealed minute,
superficial ulcera at the terminal ileum just behind the Kock’s pocket (Fig 2).
Biopsies of the affected skin (biopsy A) and of the skin-mucosa transition (B
and C) were taken; an intestinal biopsy (D) of the ulcerous ileal mucosa was
obtained during endoscopy.
The histologic diagnosis of biopsies A-C was akanthosis without signs of
koilocytosis. The skin biopsy showed epidermal hyperplasia, hyperortho- and
parakeratosis, hypergranulosis, and papillomatosis (Fig 3). Biopsy D showed an
acute ulcerous inflammation and detached intestinal epithelial cells. Neither
signs of malignancy nor signs of koilocytosis were detectable.
The patient was locally treated with three cycles of podophyllotoxin solution
in August 1995. The therapy had no effect. In December 1995 the external
parts of the papillomatous lesions were removed by a CO2 laser swift lase. Four
weeks later the lesions recurred. The patient was then referred to a medical
laser center in Berlin, Germany. Direct and endoscopically controlled Nd-YAG
laser were without persistent effect. The same was true for the use of toluidine
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Figure 1. Peristomal lesion. Greyish-white, papillomatous leukoplakia-like
plaque on the upper circumference of the ileostoma.
Figure 2. Ulcerations of the intestinal mucosa. Endoscopy showed minute
superficial ulcerations (arrows) of the terminal ileum adjacent to the stoma.
photodynamic therapy alone and combined with CO2 laser evaporation (three
sessions between 1996 and July 1997). A second biopsy from the leukoplakia-
like lesion located within the ileostoma showed a benign polyploid mucosal
hyperplasia.
Sample preparation and polymerase chain reaction (PCR) Formalin-
fixed paraffin-embedded tissues were processed with the QIAamp Tissue Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Ten
microliters of purified total cellular DNA were employed in each PCR reaction
(25 ng DNA per µl as determined by ethidium bromide fluorescent quantitation;
Sambrook et al, 1989). Each sample was analyzed with three different PCR
protocols suitable for the detection of genital (GP5 1/6 1 PCR), (muco)cutane-
ous/EV (CPIIG/IIS/CPI PCR), and EV-HPV-types (CP65–70 PCR), respect-
ively. PCR were performed as described previously (Tieben et al, 1993;
Berkhout et al, 1995; de Roda Husman et al, 1995). An enzyme mix
with proofreading activity (Expand High Fidelity PCR System, Boehringer,
Mannheim, Germany) was used. β-globin PCR was performed with all biopsies
to demonstrate that the samples contained adequate DNA and were free of
substances inhibitory to PCR (Saiki et al, 1985). To avoid PCR contamination,
the suggestions of Kwok (1990) were diligently considered. Five negative
controls (water instead of patient samples and HPV-negative paraffin embedded
tissues) were included in each PCR run; 0.1 pg full-length HPV8, HPV1a,
and HPV16 plasmid served as positive controls (Danos et al, 1980; Seedorf et al,
1986; Steger et al, 1990).
Cloning and sequencing of PCR products CP65–70 positive PCR
products were cloned into pUC19 (Boehringer). Internal PCR was repeated
with CP66/CP69 primers (Berkhout et al, 1995) that carried BamH1 and
EcoR1 sites at their 59 ends, respectively. The internal PCR product (374–
389 bp) was purified (QIAquick spin PCR purification kit, Quiagen), digested
(BamH1/EcoR1), and cloned into dephosphorylated BamH1/EcoR1-digested
pUC19 using T4 DNA ligase (GibcoBRL, Eggenstein, Germany) and CaCl2
transformation of Escherichia coli DH5α (Clontech, Paloalto, CA) (Sambrook
Figure 3. Leukoplakia-like HPV-positive lesion. (a) Histology of the
leukoplakia-like plaque (biopsy A) revealed epidermal hyperplasia with
hyperortho- and parakeratosis, hypergranulosis, and papillomatosis (hematoxylin
and eosin; scale bar, 250 µm). (b) Magnification from (a); scale bar, 25 µm.
et al, 1989). Both strands of those clones that were shown to carry a BamH1/
EcoR1 insert were sequenced using reagents and conditions supplied with the
T7 sequencing kit (Pharmacia Biotech, Freiburg, Germany). Some of the
CP66/69 PCR products had an internal EcoR1 site and thus the cloned
sequences were shorter than the expected size of µ380 bp (Table I).
Sequence analyses, alignments, and phylogenetic analyses Sequence
analyses, alignments, and phylogenetic analyses were performed as described
previously (Wieland et al, 1994, 1997). MacVector 6.0 and AssemblyLIGN 1.0
(Oxford Molecular Group PLC, U.K., 1996) were used for translation of
nucleotide sequences and alignments. Phylogenetic analyses were performed
with the ‘‘Heidelberg Unix Sequence Analysis Resources’’ (HUSAR, German
Cancer Research Center, Heidelberg, Germany). Unrooted phylogenetic trees
were calculated according to the ‘‘neighbor joining method’’ (Saitou and Nei,
1987). Bootstrapping was employed on all data sets to evaluate confidence
levels for the groupings of a tree (Felsenstein, 1985). Over 100 published HPV
L1 sequences served as reference sequences for the alignments and phylogenetic
analyses (Myers et al, 1996).
RESULTS
Detection of HPV DNA in four peristomal lesions All biopsies
were tested by three different PCR protocols for genital (GP51/61
and CPII/I PCR), cutaneous (CPII/I PCR), and EV- (CPII/I and
CP65–70 PCR) HPV types (Tieben et al, 1993; de Roda Husman
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Table I. HPV typing
Biopsy Clone(s) HPV typea Closest relative % Homology (DNA) HPV groupb
A A1–A5 S-A HPV17 76.6% (258 of 337 nt) B1
skin
B B1, B4 S-B HPV15 82.8% (159 of 192 nt) B1 b1
transition B2, B5 S-B/X2 HPV24 64.1% (66 of 103 nt) B1
skin/mucosa B3, B6 HPV23 HPV23 97.9% (185 of 189 nt) B1 b2
reference type
C C1–C5 HPV38 HPV38 99.0% (190 of 192 nt) B1 b2
transition reference type
skin/mucosa
D D1 HPV23 HPV23 97.4% (184 of 189 nt) B1 b2
ileal D2–D5 HPV20 HPV20 100% (201 of 201 nt) B1 a2
mucosa D6 S-D HPV38 82.6% (281 of 340 nt) B1 b2
aHPV typing was performed by dideoxy chain termination sequencing of cloned HPV L1 fragments and alignment with 150 known HPV L1 reference sequences.
bHPV groups according to Chan et al (1995) and Myers et al (1996) (see text for details).
et al, 1995; Berkhout et al, 1995). HPV-specific sequences could not
be detected in any of the biopsies when repeatedly tested with GP51/
61 or CPII/I PCR; however, HPV-specific DNA fragments of the
expected length (374–389 bp) were readily detectable in all four
biopsies with CP65–70 PCR. Of each biopsy, the internal PCR
product generated with primers CP66/69 was cloned into the vector
pUC19 as described in Materials and Methods. Five or six clones were
obtained from each sample (Table I).
Identification of novel EV-HPV sequences HPV typing was
performed by sequencing of cloned HPV L1 fragments and comparison
of the sequences located between the primers with 150 known HPV
L1 sequences (Myers et al, 1996). In the four biopsies we found seven
different HPV L1 sequences: HPV20, HPV23, HPV38, a subtype of
the putatively new HPV type RTRX2 (S-B/X2), and three further
sequences representing putatively novel HPV types (Table I). The
latter were named S-A, S-B, and S-D. RTRX2 is a new HPV L1
sequence [276 nucleotides (nt)] recently described by Berkhout et al
(1995). Seventy-two nucleotides of S-B/X2 overlapped with RTRX2
and in this overlap S-B/X2 and RTRX2 were 95.8% identical (69 of
72 nt), thus probably representing subtypes of the same HPV type.
The closest relatives of S-A, S-B, and S-D were HPV17, HPV15, and
HPV38, respectively (Table I, Fig 4). The nucleotide sequences of
S-A, S-B, and S-D differed by more than 10% from their closest
relatives (23.4%, 17.2%, 17.4%, respectively), and thus represent
putatively new HPV types. At the amino acid level the differences to
their closest relatives were 20.5% (23 of 112 amino acids) for S-A,
15.6% (10 of 64 amino acids) for S-B, and 18.6% (21 of 113 amino
acids) for S-D (Fig 4). 159 nt of S-B overlapped with a putatively novel
HPV sequence named X29 (R. Berkhout, University of Amsterdam, the
Netherlands, personal communication). S-B and X29 were almost
identical (158 of 159 nt, 99.4%). Each of the new HPV sequences
were only found in one of the four biopsies, respectively. The number
of HPV sequences found per lesion varied between one and three.
Biopsies A and C carried only one HPV sequence each: identical S-A
and HPV38 sequences were found in all clones of these lesions,
respectively. Three different HPV sequences were found in biopsy B
(S-B, S-B/X2, HPV23) and in biopsy D (HPV20, HPV23, S-D).
HPV23 was the only HPV type that occurred in more than one biopsy,
namely in biopsies B and D (Table I).
Phylogenetic analyses of the novel HPV L1 sequences and of 26
reference sequences showed that S-A, S-B, and S-D clustered with
HPV L1 sequences of the HPV group B1 (Fig 5). According to the
Los Alamos National Laboratory HPV sequence database (Myers et al,
1996), the phylogenetic tree of group B1 forms two major branches
each of which is subdivided in two minor branches, resulting in the
clusters a1, a2, b1, and b2, besides some isolated branches (compare
with legend to Fig 5). In the tree shown in Fig 5, S-B, S-B/X2, and
S-D were located next to the HPV types that were identified as their
closest relatives by sequence alignments (Table I) and their position
in the tree was corroborated by bootstrap values above 800. S-B and
S-D were assigned to the B1 clusters b1 and b2, respectively. RTRX2
has previously been classified as an isolated type within the group B1
(Myers et al, 1996). The position of S-A in the tree was not stable
(224 of 1000 and 240 of 1000 bootstrap replicates) and thus it was not
assigned to any cluster.
DISCUSSION
In this study we have investigated recurrent skin and mucosal leuko-
plakia-like lesions of a stoma-carrier that were refractory to therapy.
By cloning and sequencing of PCR products, we have found seven
different HPV L1 DNA sequences in four biopsies of the leukoplakial
lesions around the ileostoma and of the adjacent ileal mucosa. PCR-
derived HPV L1 sequence fragments are suitable for HPV typing
(Bernard et al, 1994; Tachezy et al, 1994). Comparison of the detected
sequences with 150 known HPV L1 sequences showed that three of
the seven L1 DNA sequences corresponded to the known HPV types
20, 23, and 38 that belong to the HPV group B1 (Chan et al, 1995;
Myers et al, 1996). Four of the detected L1 DNA sequences differed
by more than 10% from any other known HPV sequence and thus
represent putatively novel HPV types. They were provisionally named
S-A, S-B, S-B/X2, and S-D. Their complete genome needs to be
cloned before they can definitively be recognized as new HPV types.
S-B/X2 is probably a subtype of the L1 sequence RTRX2 that was
recently found in a squamous cell carcinoma (SCC) (Berkhout et al,
1995). Phylogenetic analyses confirmed that S-A, S-B, and S-D
belonged to the HPV group B1 (Fig 5). Group B1 comprises HPV
types associated with the rare skin disease EV and several new HPV
L1 sequences (Myers et al, 1996). These new HPV B1 sequences as
well as established EV-HPV types were recently detected in benign
(papillomas, warts, keratoacanthomas), premalignant (actinic keratoses,
Bowen’s disease), and malignant (Bowen’s carcinomas, basal cell carcin-
omas, SCC) skin tumors (Tieben et al, 1994; Berkhout et al, 1995; de
Jong-Tieben et al, 1995; Shamanin et al, 1996; Ho¨pfl et al, 1997).
Leukoplakial lesions around a stoma as in the patient investigated here,
have, to our knowledge, not yet been described before. Concerning
HPV and the digestive tract, HPV types 2, 6, 11, 16, and 18 have
been found in benign and (pre)malignant oral leukoplakias, but the
role of HPV in oral leukoplakia is not yet clear (Gassenmeier and
Hornstein, 1988; Wen et al, 1997). Some studies have associated HPV
types 6, 11, 16, and 18 with oral and esophageal cancer and one
novel HPV B1 sequence named ‘‘Togawa’’ was recently found in an
esophageal SCC (IARC, 1995; Togawa and Rustgi, 1995; Myers et al,
1996). Although we used PCR protocols suitable for the detection of
mucosal and typical cutaneous HPV, we only found HPV group B1
sequences in the patient investigated here. The PCR protocol that
yielded positive results in this study was specifically designed to detect
EV-HPV types at low copy numbers, but it is also suitable for the
amplification of some mucosal HPV types as HPV6, HPV11, HPV13,
HPV16, HPV18, HPV31, and HPV33 (Berkhout et al, 1995). This is
to our knowledge, the first detection of EV-HPV types in an intestinal
lesion. It has to be considered, however, that the intestinal mucosa
described here differed from normal intestinal mucosa: due to the
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Figure 4. Novel HPV L1 sequences. DNA and, above, deduced amino acid
sequences of the new HPV L1 sequences S-A, S-B, S-B/X2, and S-D compared
with their closest relatives, respectively (for details see text and Table I). (a) S-
A (337 nt) and HPV17 (nt 6752–7091; Delius and Hofman, 1994); (b) S-B
(192 nt) and HPV15 (nt 6731–6922; Delius and Hofman, 1994); (c) S-B/X2
(103 nt) and HPV24 (nt 6753–6855; Delius, DKFZ, Heidelberg, Germany,
unpublished, 1995); (d) S-D (340 nt) and HPV38 (nt 6686–7026; Delius,
unpublished, 1995). Conserved positions are shown by points, and gaps are
indicated by dashes. GenBank accession numbers are AF012460–AF012461.
stoma surgery it had direct contact to the skin. Two of the lesions
investigated by us contained only one HPV type each, and the two
other lesions carried three different HPV types each (Table I). These
findings are in accordance with previous studies of HPV-associated
Figure 5. Phlyogenetic analysis of the novel HPV L1 gene sequences.
The phylogenetic unrooted tree was calculated according to the neighbor
joining method of Saitou and Nei (1987) (for details see Materials and Methods).
The four novel HPV L1 sequences, S-A, S-B, S-B/X2, and S-D, and 26 HPV
L1 group B1 reference sequences (Myers et al, 1996) of the corresponding
lengths were employed in the analysis. Bootstrap values above 500 are shown.
The scale bar represents percentage divergence along the branches. L1 sequences
found in the investigated patient are shown in bold letters. The branch of S-
B/X2 was shortened (dotted line) because the differences to RTRX2 were over-
represented due the reduced length of S-B/X2. Of the group B1 reference
sequences shown in the tree (from right to left), HPV19, HPV25, HPV20,
HPV14, and HPV21 belong to cluster a2; HPV5, HPV36, HPV47, HPV12,
ICPX1, and HPV8 belong to cluster a1; RTRX4, RTRX5, HPV24, and
RTRX2 are not classified; HPV17, HPV37, RTRX3, HPV9, and HPV15
belong to cluster b1; and RTRX1, HPV23, HPV 22, HPV 38 belong to cluster
b2; RTRX6 and HPV49 are not classified (Myers et al, 1996) (compare with text).
skin lesions. Berkhout et al (1995) detected more than one HPV type
in over 30% of SCC biopsies. Similarily, Shamanin et al (1996) found
up to four different HPV sequences in SCC and basal cell carcinomas,
and up to two different HPV sequences in common warts of renal
transplant recipients. The four biopsies investigated here were shown
to carry different HPV types, respectively. The only type that was
found in two of the biopsies was HPV23. HPV23 occurred at the
transition skin/mucosa and in the ileal mucosa (Table I). Because the
patient had had the habit of regularly flushing her ileostoma, HPV
particles or virus-containing cells could have been carried from the
skin surrounding the stoma to the intestinal mucosa. The two other
HPV sequences found in the intestinal lesion (HPV20 and S-D) did
not occur in any of the other biopsies, however. The detection of
HPV-DNA by PCR does not necessarily prove that the patient’s
peristomal lesions were caused by an HPV infection; however, the
histology of biopsies A–C, the clinical similarity with leukoplakias, and
the strong tendency to reoccur after therapy, which is typical for many
HPV-induced lesions, make a causal connection between the peristomal
pathology and the detected HPV types likely.
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